Clinical Trials Browser

Recruiting × Prostatic Neoplasms × tazemetostat × Clear all

NCT07407283 2026-04-21

A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer

Phase 1/2 Recruiting

Prostatic Neoplasms